• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

320 例葡萄膜黑色素瘤的基因组特征:8p 染色体缺失与转移结局。

Genomic profile of 320 uveal melanoma cases: chromosome 8p-loss and metastatic outcome.

机构信息

Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

出版信息

Invest Ophthalmol Vis Sci. 2013 Aug 23;54(8):5721-9. doi: 10.1167/iovs.13-12195.

DOI:10.1167/iovs.13-12195
PMID:23821189
Abstract

PURPOSE

Uveal melanoma (UM) was a fatal malignancy in 40% to 50% of cases. The aim of this study is to evaluate the independent contributions of chromosome 1, 3, 6, and 8 abnormalities for prognostication of metastasis, and to define multichromosome copy number aberration (CNA) signatures that can be used to evaluate risk.

METHODS

A series of 320 UM were analyzed for chromosome 1, 3, 6, and 8 abnormalities using whole genome single-nucleotide polymorphism arrays. Results for changes in six chromosomal regions were analyzed using univariate and multivariate Cox proportional hazard modeling to identify significant predictors of metastasis and CNA signatures.

RESULTS

Univariate Cox analysis indicated that losses of chromosome 3, 1p, 6q, and 8p and gain of 8q, as well as sex, source of tumor tissue (fine-needle aspiration biopsy [FNAB] compared with tumor from an enucleated eye), tumor basal diameter and height, and ciliary body involvement were all significant predictors of poor metastatic outcome. In the multivariate analysis, loss of chromosome 3 and 8p remained significant after adjusting for the effects of all other variables, as did sex, tissue source, and basal diameter. Multivariate analysis of the joint effects of changes in the six chromosomal regions showed that six signatures, including chromosome 3-loss, 1p-loss, 8p-loss, and/or 8q-gain had hazard ratios (HR) ranging from 7.90 to 37.25.

CONCLUSIONS

In UM, tumor size and location, tissue source, and sex were all significantly associated with increased metastasis. In addition, chromosome 3-loss and 8p-loss were found to be independent predictors of poor metastatic outcome and CNA signatures were identified that can add a specific HR value for classification of risk categories.

摘要

目的

葡萄膜黑色素瘤(UM)在 40%至 50%的病例中是致命的恶性肿瘤。本研究旨在评估染色体 1、3、6 和 8 异常对转移的独立预后贡献,并定义可用于评估风险的多染色体拷贝数异常(CNA)特征。

方法

使用全基因组单核苷酸多态性芯片分析了 320 例 UM 的染色体 1、3、6 和 8 异常。使用单变量和多变量 Cox 比例风险模型分析了六个染色体区域变化的结果,以确定转移的显著预测因子和 CNA 特征。

结果

单变量 Cox 分析表明,染色体 3、1p、6q 和 8p 的缺失以及 8q 的增益,以及性别、肿瘤组织来源(细针抽吸活检 [FNAB] 与眼内容物切除的肿瘤相比)、肿瘤基底直径和高度以及睫状体受累都是不良转移结果的显著预测因子。在多变量分析中,在调整了所有其他变量的影响后,染色体 3 和 8p 的缺失仍然是显著的,性别、组织来源和基底直径也是如此。对六个染色体区域变化的联合效应进行多变量分析显示,包括染色体 3-缺失、1p-缺失、8p-缺失和/或 8q-增益在内的六个特征的危险比(HR)范围为 7.90 至 37.25。

结论

在 UM 中,肿瘤大小和位置、组织来源和性别均与转移增加显著相关。此外,染色体 3-缺失和 8p-缺失被发现是不良转移结果的独立预测因子,并且确定了 CNA 特征,可以为风险分类增加特定的 HR 值。

相似文献

1
Genomic profile of 320 uveal melanoma cases: chromosome 8p-loss and metastatic outcome.320 例葡萄膜黑色素瘤的基因组特征:8p 染色体缺失与转移结局。
Invest Ophthalmol Vis Sci. 2013 Aug 23;54(8):5721-9. doi: 10.1167/iovs.13-12195.
2
The prognostic value of extraocular extension in relation to monosomy 3 and gain of chromosome 8q in uveal melanoma.葡萄膜黑色素瘤中外眼延伸与单体型 3 和 8q 染色体增益相关的预后价值。
Invest Ophthalmol Vis Sci. 2014 Mar 4;55(3):1284-91. doi: 10.1167/iovs.13-13670.
3
Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.在葡萄膜黑素瘤细胞中,更高比例的 FISH 确定的单体 3 和 8q 扩增与患者预后不良有关。
Invest Ophthalmol Vis Sci. 2012 May 14;53(6):2668-74. doi: 10.1167/iovs.11-8697.
4
Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.转移性原发性葡萄膜黑色素瘤中3号染色体的伴随性缺失以及1号、6号或8号染色体的整条臂的缺失和增加。
Invest Ophthalmol Vis Sci. 2001 Feb;42(2):313-7.
5
Personalized Prognosis of Uveal Melanoma Based on Cytogenetic Profile in 1059 Patients over an 8-Year Period: The 2017 Harry S. Gradle Lecture.基于 8 年 1059 例患者细胞遗传学特征的葡萄膜黑色素瘤个体化预后:2017 年哈里 S.格拉德讲座。
Ophthalmology. 2017 Oct;124(10):1523-1531. doi: 10.1016/j.ophtha.2017.04.003. Epub 2017 May 7.
6
Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.多重连接依赖性探针扩增等同于荧光原位杂交,可用于鉴定葡萄膜黑色素瘤中转移性疾病风险患者。
Melanoma Res. 2012 Feb;22(1):30-7. doi: 10.1097/CMR.0b013e32834e6a67.
7
Cytogenetics of uveal melanoma: a 7-year clinical experience.葡萄膜黑色素瘤的细胞遗传学:7年临床经验
Ophthalmology. 2007 Oct;114(10):1925-31. doi: 10.1016/j.ophtha.2007.06.012. Epub 2007 Aug 27.
8
Clinical and cytogenetic analyses in uveal melanoma.葡萄膜黑色素瘤的临床与细胞遗传学分析
Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3703-7. doi: 10.1167/iovs.06-0101.
9
Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8.一例葡萄膜黑色素瘤患者6号染色体存在区域缺失和扩增,而1p、3号和8号染色体无异常。
Melanoma Res. 2008 Feb;18(1):10-5. doi: 10.1097/CMR.0b013e3282f1d4d9.
10
Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization.利用荧光原位杂交技术检测葡萄膜黑色素瘤活检组织中的基因预后标志物。
Clin Cancer Res. 2002 Feb;8(2):534-9.

引用本文的文献

1
variants and copy number alterations prognostically stratify patients with sinonasal melanoma.基因变异和拷贝数改变可对鼻窦黑色素瘤患者进行预后分层。
Pathologica. 2025 Apr;117(2):121-130. doi: 10.32074/1591-951X-1088.
2
State-of-the-art in Metastatic Uveal Melanoma Treatment: A 2025 Update : How to treat Metastatic Uveal Melanoma in 2025.转移性葡萄膜黑色素瘤治疗的最新进展:2025年更新版:如何在2025年治疗转移性葡萄膜黑色素瘤。
Curr Oncol Rep. 2025 May 17. doi: 10.1007/s11912-025-01684-0.
3
Genetic landscape of uveal melanoma in Southeast Asia: high 1q gains and unique patterns of metastasis risk.
东南亚葡萄膜黑色素瘤的基因图谱:1q高增益及转移风险的独特模式
Eye Vis (Lond). 2025 Apr 16;12(1):15. doi: 10.1186/s40662-025-00430-8.
4
Clinical Value of MLPA for Prognostic Assessment of Chromosomal Rearrangements and DNA Methylation in Uveal Melanoma.多重连接探针扩增技术(MLPA)在葡萄膜黑色素瘤染色体重排和DNA甲基化预后评估中的临床价值
Invest Ophthalmol Vis Sci. 2025 Mar 3;66(3):51. doi: 10.1167/iovs.66.3.51.
5
Genome-Wide Methylation Patterns in Primary Uveal Melanoma: Development of MethylSig-UM, an Epigenomic Prognostic Signature to Improve Patient Stratification.原发性葡萄膜黑色素瘤的全基因组甲基化模式:甲基化特征UM的开发,一种用于改善患者分层的表观基因组预后特征。
Cancers (Basel). 2024 Jul 25;16(15):2650. doi: 10.3390/cancers16152650.
6
Single cell RNA-sequencing in uveal melanoma: advances in heterogeneity, tumor microenvironment and immunotherapy.单细胞 RNA 测序在葡萄膜黑色素瘤中的应用:异质性、肿瘤微环境和免疫治疗的研究进展。
Front Immunol. 2024 Jun 20;15:1427348. doi: 10.3389/fimmu.2024.1427348. eCollection 2024.
7
Recent Advances in Molecular and Genetic Research on Uveal Melanoma.葡萄膜黑色素瘤的分子遗传学研究进展
Cells. 2024 Jun 12;13(12):1023. doi: 10.3390/cells13121023.
8
Pathological and Molecular Diagnosis of Uveal Melanoma.葡萄膜黑色素瘤的病理与分子诊断
Diagnostics (Basel). 2024 May 2;14(9):958. doi: 10.3390/diagnostics14090958.
9
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy.黑色素瘤的异质性和分子特征:对靶向治疗的影响。
Mol Biomed. 2024 May 10;5(1):17. doi: 10.1186/s43556-024-00182-2.
10
Significance of Aneuploidy in Predicting Prognosis and Treatment Response of Uveal Melanoma.非整倍体在预测葡萄膜黑色素瘤预后及治疗反应中的意义
Curr Med Chem. 2025;32(3):579-594. doi: 10.2174/0109298673286788240123044411.